Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
9°
Light Snow
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tempest Therapeutics Inc
(NQ:
TPST
)
0.9599
+0.0195 (+2.07%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tempest Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Tempest to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
August 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 15, 2023
Via
Benzinga
Tempest Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
Analyst Ratings for Tempest Therapeutics
May 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
Tempest Announces Publication in Cancer Research Communications Highlighting TPST-1495 Significantly Increased Potency Against Prostaglandin-Driven Tumor Models by Blocking EP2 and EP4 Together
July 19, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 12, 2023
Via
Benzinga
Tempest to Present at the Jefferies Global Healthcare Conference
May 31, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest to Present Phase 1 Monotherapy and Combination Data at ASCO for TPST-1495 in Patients with Advanced Cancers
May 25, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest Reports First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study: Analysts Get Bullish
April 28, 2023
Tempest Therapeutics Inc (NASDAQ: TPST) announced
Via
Benzinga
Dow Surges Over 200 Points; Exxon Mobil Earnings Beat Views
April 28, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 200 points on Friday. The Dow traded up 0.63% to 34,039.34 while the NASDAQ rose 0.35% to 12,184.79. The S&P 500, also...
Via
Benzinga
Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 28, 2023
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.
Via
Benzinga
Tempest Therapeutics (NASDAQ: TPST) Reports Strong Early Results From Phase 1b/2 Study of TPST-1120 in Hepatocellular Carcinoma
April 28, 2023
Tempest Therapeutics, Inc. (NASDAQ: TPST) is engaged as a clinical-stage oncology company, which is focused on the research and development
Via
Spotlight Growth
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 28, 2023
Via
Benzinga
Tempest Announces Positive Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
April 28, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest to Report Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
April 27, 2023
Webcast Conference Call Friday, April 28, 2023, at 8:30 a.m. ET
From
Tempest Therapeutics
Via
GlobeNewswire
Tempest Announces TPST-1495 Poster Presentation at the 2023 ASCO Annual Meeting
April 26, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 19, 2023
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 18, 2023
Via
Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 18, 2023
Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...
Via
Benzinga
Tempest Announces New Translational and Preclinical Data Presented at the 2023 AACR Annual Meeting
April 17, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
April 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 29, 2023
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
Via
Benzinga
Tempest Reports Year End 2022 Financial Results and Provides Business Update
March 22, 2023
From
Tempest Therapeutics
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.